MedTrace Logo

Cognitive Bias Modification for Interpretation Individuals With Chronic Musculoskeletal Pain

NCT06368362 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2024-04-16

No results posted yet for this study

Summary

Cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as neutral or benign, rather than interpret it as being related to pain. The goal of this randomised controlled trial was to explore the feasibility and potential clinical benefits of CBM-I in people with chronic pain and also healthy, pain-free individuals.

Conditions

Interventions

BEHAVIORAL

Benign cognitive bias modification for interpretation

Benign cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as neutral or benign rather than pain-related.

BEHAVIORAL

Pain-related cognitive bias modification for interpretation

Pain-related cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as pain-related.

Sponsors & Collaborators

  • Economic and Social Research Council, United Kingdom

    collaborator OTHER

  • University of Southampton

    lead OTHER

Principal Investigators

  • Daniel E Schoth, PhD · University of Southampton

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-17
Primary Completion
2021-05-01
Completion
2021-05-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06368362 on ClinicalTrials.gov